Tarsus Pharmaceuticals, Inc. TARS Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s intangible assets — net?
- Tarsus Pharmaceuticals, Inc. (TARS) reported intangible assets — net of $7.13M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s intangible assets — net changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s intangible assets — net decreased by 11.9% year-over-year, from $8.09M to $7.13M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s intangible assets — net?
- Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s intangible assets — net has grown at a 38.0% compound annual growth rate (CAGR), from $3.87M to $7.37M.